Hospital-acquired Infection Control Market Forecast 2023 to 2033 | By Component, End- User & Region

Future Market Insights recently published a report on the Hospital-acquired Infection Control Market, predicting global sales of US$ 6.5 billion in 2023. From 2023 to 2033, the Hospital-acquired Infection Control market demand is estimated to rise at a CAGR of 7%, reaching US$ 12.7 billion by 2033, with hospitals and critical care units expected to contribute considerable revenue at a CAGR of 7.6%.

The frequent occurrence of Hospital-acquired Infections, the increasing proportion of surgical procedures, the rising geriatric population, the growing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are all driving the growth of the Hospital-acquired Infection Control market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16573

The market for Hospital-acquired Infection Control is also predicted to develop due to the increased usage of e-beam sterilisation and the reintroduction of ethylene oxide sterilisation.

The increase in the number of surgical procedures conducted worldwide, which currently stands at roughly 235 million difficult surgeries each year, is creating even more demand for surgical equipment and medical gadgets. Demand for sterilised product lines is projected to boost demand for hospital-acquired infection services, as is growing awareness of their effectiveness in healthcare settings.

The Asia Pacific region, particularly Japan, is expected to grow at a CAGR of more than 7% during the forecast period as a result of rising demand for Hospital-acquired Infection Control methods in developing countries, rising awareness of general health and fitness among the working-class population, and widespread use of Hospital-acquired Infection Controls in the region.

In conclusion, the Hospital-acquired Infection Control market is likely to grow significantly in the coming years, driven by a variety of causes, and each area presents unique potential and challenges for market participants.

For critical insights on this market, request to ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16573

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:

• To expand its large array of sterilisation services, STERIS purchased Cantel, a global producer of infection control products and services, through a U.S. subsidiary in 2021.
• Sterigenics S.A.S., a Sotera Health Company subsidiary, expanded its ethylene oxide production in Rantigny, France, in 2021, increasing its European sterilising capacity. In 2020, Getinge launched the Getinge Solsus 66 steam steriliser for hospitals and surgical equipment, which has a greater capacity and operational reliability than previous sterilisers.
• Sotera Health Company bought Iotron, a major North American outsourced provider of E-beam sterilisation services, in 2020. The acquisition was made to assist the company in expanding its electron beam footprint and increasing sales of the Sterigenics segment.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Hospital-acquired Infection Control Market, presenting historical market data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16573

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis

By Component:

• Equipment

• Sterilization Equipment
• Disinfection Equipment

• Consumables

• Disinfectants
• Sterilization Consumables
• Others (Waste Disposal, PPE)

• Services

By End-user:

• Hospitals and Intensive Care Units
• Ambulatory Surgical and Diagnostic Centers
• Other End-users

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs